Jinan Trio PharmaTech Co., Ltd
Lab/Research institutions

地址:2766 Yingxiu Road, Jinan High-Tech Zone, China China (Mainland) Jinan Shandong

主营产品:

主要市场:North America Eastern Europe Southeast Asia Oceania Western Europe

业务范围:Crizotinib,Vemurafenib,Afatinib ,Vandetanib ,Regorafenib,Brivanib alaninate and their intermediates;Pyridazine,Imidazole,Indoles,Thiazole,Pyrazoles Oxazole

注册资本: 1000000

公司规模:11 - 50People

成立年份:2009

法人代表:Sun Xueying

Yan

86-531-88811783;+(0)13153010282+(0)13153010282

sales@trio-pharmatech.com

www.trio-pharmatech.com







Jinan Trio PharmaTech Co., Ltd. locates at one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City. It was founded by a core group of top overseas pharmaceutical chemists, Medical scientists and business management experts, and is an enterprise of science and technology supported by the "Attracting High-Level Talent Scheme" of Jinan government.


The company integrates research and development (R&D), manufacture, sales and training, and focuses on developing novel anti-cancer drugs, their intermediates and heterocyclic compounds. It has built up solid cooperation with several domestic and international universities and research institutes.


The company has a consummate management system, and advocates the concepts of "GLP (Good Laboratory Practice), GMP (Good Manufacture Practice) and GSP (Good Supply Practice)". No complaint about the quality of the products has been received from the customers since its establishment in 2008.


Our mission is "Research, Green and Innovation". We try wholeheartedly to provide high-quality products from rational process and of competitive price, and services ranging from drug R&D to intermediate synthesis.